Direct-acting antivirals improve survival and recurrence rates after treatment of hepatocellular carcinoma within the Milan criteria.
Hironori OchiAtsushi HiraokaMasashi HirookaYohei KoizumiMichiko AmanoNobuaki AzemotoTakao WatanabeOsamu YoshidaYoshio TokumotoToshie MashibaTomoyuki YokotaMasanori AbeKojiro MichitakaYoichi HiasaKouji JokoPublished in: Journal of gastroenterology (2020)
DAAs after HCC treatment prevents deterioration of hepatic functional reserve and significantly improves both recurrence and survival rates.